Waram al rahim (Pelvic Inflammatory Disease) is a polymicrobial infection and one of the most common causes of morbidity in young women in both the developing and developed world. About 10-20 per 1000 fertile women suffers from PID. The spectrum of disease ranges from subclinical, asymptomatic infection to severe, life-threatening illness. Objective: The aim of the study was to evaluate the efficacy of arq mako and sharbat kasni in the management of stage I PID. Methodology: This clinical study was carried out at NIUM Hospital, Bengaluru during the year of 2016-17. Total 30 patients between 18-45 years were included and arq mako 60 ml and sharbat kasni 10 ml was administered orally twice daily for 21 days. Follow up done weekly during trial and every 15 days for one month after trial. Primary and secondary outcome measures were assessed before and after trial. Result: Statistical analysis were done by using Fisher exact, Mc Nemar and paired T test to assess improvement in sign, symptoms of PID. Results were categorized into three groups. Out of 30 (100%) patients 70% were cured on 3rd week of trial, 23.33% were relieved and only 6.67% had no response. Both primary and secondary outcome measures were statistically strongly significant. Interpretation and conclusion: From the present study it can be concluded that Arq mako and sharbat kasni was effective in stage I PID and can be used in daily practice. It also observed that there were no adverse effects of the drugs during the trial.